Elixir Pharmaceuticals

About:

Elixir Pharmaceuticals develops and commercializes pharmaceuticals for the treatment of metabolic diseases.

Website: http://elixirpharm.com

Top Investors: Hercules Capital, ARCH Venture Partners, Omega Funds, JAFCO Asia, MPM Capital

Description:

Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. The Company's scientific founders identified that interactions between specific genes and enzymes can slow the aging process, and they are developing compounds that stimulate these interactions and will be used to treat a range of diseases of aging, including metabolic disease.